Sign in
Prognostic Value of Subretinal Hyperreflective Material
Russell Pokroy, MD
Updates from the Field
2017
Anti-VEGF treatment switch in DME and nAMD: a comparison of aflibercept versus ranibizumab after a single-dose switch
Estephania Feria, MD
On Demand Cases, Courses, and Papers
2019
Abicipar Phase 2 MAPLE Trial Supports Improved Safety for Patients with nAMD Following a Modified Manufacturing Process
Raj K. Maturi, MD
Category: Imaging – Digital-Fluorescein angiography